백메가

비상장

Inc. 100Mega

신정권

Investment Review Report

Auto-filled from disclosures & public data + AI-drafted analysis. Edit, then export to PDF/DOCX.

Editor

1.Deal Terms

2.Valuation / Exit Assumptions

Exit Scenarios100M KRW

3.Fund Eligibility

Fund mandate eligibility — no data, enter manually

Enter fund mandate requirements and applicability (Y/N) to include a table in the report.

4.Capital Changes

Not in DART — enter capital-raise history manually

Enter capital changes such as founding capital and paid-in increases.

5.Stock Options

Enter manually

Enter stock option grant history.

6.Investment Highlights

AI draft — editable

Click 'Generate AI draft' to populate data-grounded investment highlights.

7.Investment Risks

AI draft — editable

Risks are populated after 'Generate AI draft'.

8.Market Analysis

AI draft — editable

9.Business Analysis

AI draft — editable

10.Conclusion (Investment Opinion)

AI draft — editable

11.P&L Projection

Analyst estimates, manual entry (100M KRW). Generates a trend chart & table.

Enter projected revenue / op. profit / net income (100M KRW) by year to add a trend chart and table.
Preview— the document below is saved as PDF/DOCX

Investment Review Report

백메가

Business Reg. No. 5038614235 · CEO 신정권

I.Investment Overview

Target백메가 (5038614235)
Investment
Post-deal stake
ValuationPre — / Post —

II.Investment Highlights

No investment highlights written yet.

III.Investment Risks

No risks written yet.

IV.Company Profile

회사명백메가
영문명Inc. 100Mega
대표자신정권
사업자등록번호5038614235
법인등록번호1701110532053
설립일2014.07.01
종업원수85명

V.Workforce

85

Current headcount · 2026.06 as of

VI.Financial Summary

Per DART disclosure · in 억/만원 (KRW)

Financial trend (100M KRW)

매출액100M KRW554.52021606.42022680.32023910.920241,0092025
영업이익100M KRW14.7202121.9202215.120237.5202415.92025
순이익100M KRW12202111.32022820238.3202423.62025
Item20252024202320222021
자산총계283.2억원235.7억원196.7억원191.8억원170.3억원
부채총계177.6억원153.7억원123.1억원118.8억원104.5억원
자본총계105.6억원81.9억원73.6억원73억원65.7억원
매출액1,009억원910.9억원680.3억원606.4억원554.5억원
영업이익15.9억원7.5억원15.1억원21.9억원14.7억원
순이익23.6억원8.3억원8억원11.3억원12억원

VII.Financial Ratios

FY2025 basis

1.58%

영업이익률

2.34%

순이익률

8.35%

ROA

22.4%

ROE

168.25%

부채비율

37.28%

자기자본비율

VIII.Valuation & Exit Plan

Exit valuation
Holding period5y
Enter exit assumptions (investment, stake, exit valuation, period) to see MOIC·IRR.

This report compiles disclosure & public data and AI-drafts some sections as a research aid. It is not investment advice; the user bears final responsibility for facts and investment decisions.

백메가 투심보고서 | Alpha Lenz